A cutting-edge software startup, secured in its funding of 4.6 million SEK, is poised to revolutionize the MedTech industry
Rekonnect, a game-changing software startup based in Malmö, has raised 4.6Msek in a successful pre-seed funding round. This marks a major milestone for the company, which is dedicated to revolutionizing post-market surveillance for medical technology companies, positioning itself as a leader in the industry and poised for even greater success in the future.
Rekonnect was established by a seasoned group of business and technology experts with a vision to create a groundbreaking solution that will disrupt the fast-evolving medical technology industry and healthcare industry. Capitalizing on the critical need for medical device manufacturers to comply with regulations, Rekonnect offers a vital solution for evaluating the post-market impact of medical devices, positioning itself as an indispensable player in the industry.
By optimizing workflows and processes that improve the overall performance of medical devices, Rekonnect brings together the key players in the MedTech world by creating a secure, centralized digital ecosystem. "We saw that selling medical devices through global distributors created a disconnect that left device-users isolated from essential support, also customer data and device usbility insights owned by distributors. We are on a mission to digitally transform and centralize the device data and user insights, and ensure companies meet MDR regulations.” says Will Gray, Co-founder and CEO. Rekonnect empowers healthcare professionals, resellers, distributors, and medical technology manufacturers to effortlessly exchange valuable data, fostering a collaborative environment that drives innovation and improves patient outcomes.
Investors comprised of Curus, LOOP Capital, Fast Track Capital, and Angcell Ventures, along with several notable angel investors including Ingela Hallberg, Emil Sjödin, and Björn Andersson. In addition, Will adds "We are thrilled to have such valuable investors onboard with a proven track record in HealthTech and B2B SaaS". The funding will be used to further develop the platform, aquire customers and expand its core team.
Rekonnect is already attracting widespread interest from wide range of potential customers and partners within Europe, and the funding will aid the company in ramping up its growth. It is confident that its distinctive approach will resonate with customers whilst distinguishing it from the competition.
Rekonnect is B2B SaaS solution designed for medical technology companies to achive post-market success. It provides advanced stakeholder relationship management, device information management, service management and more.
Co-founder and CEO, Will Gray